US legislators and government agencies take aim at pharma patent strategies
The Senate Judicial Committee has advanced several IP bills targeting life sciences rights owners
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the IAM experts.